Developing New Weight Loss Surgery Techniques
Dr. Mitchell Roslin is the Principal Investigator of the Restore Trial. This is a 10-center national study that is investigating whether an endoscopic suturing technique can be used to modify the outlet in gastric bypass surgery for patients who have regained weight or never lost an adequate amount of weight. This is an FDA approved trial that is listed on the clinical trials registry. It is only being performed at leading academic medical centers like Northern Westchester Hospital. Medical fees for the trial are covered by the sponsor, C. R. Bard.
Dr. Roslin is the Principal Investigator for Vagus Nerve Stimulation for Obesity. This clinical trial examined the use of nerve stimulation of the major nerve of the digestive tract to mimic satiety in obese individuals. During this clinical trial several bariatric patients had significant weight loss. Dr. Roslin holds several patents in this area, and this is an active area of investigation for future treatments.
Dr. Roslin holds several patents and patent applications for novel approaches to weight loss surgery. He has licensed patents to C.R. Bard on endoscopic obesity treatments, and Cyberonics for vagus nerve stimulation. He additionally has a patent application for a novel band product that is being developed. Dr. Roslin is based out of Northern Westchester Hospital in Mount Kisco, New York, a facility proudly serving New York City and the rest of the state.
To take advantage of the expertise of Dr. Mitchell Roslin, who is on the cutting edge of new weight loss surgery techniques, visit his contact page to select the office nearest you, or call our general number at 877.677.1077.